— Know what they know.
Not Investment Advice

FOCL NASDAQ

EDAP TMS S.A. American Depositary Shares
1W: +9.6% 1M: +21.8% YTD: +39.1%
$6.06
-0.09 (-1.46%)
 
Weekly Expected Move ±3.0%
$6 $6 $6 $6 $6
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 66 · $227.1M mcap · 37M float · 0.117% daily turnover · Short 39% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$227.1M
52W Range1.21-6.18
Volume120,374
Avg Volume43,501
Beta-0.03
Dividend
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEORyan Rhodes
Employees289
SectorHealthcare
IndustryMedical - Devices
IPO Date1997-08-01
Parc d’Activites la Poudrette-Lamartine
Vaulx-en-Velin, ARA 69120
FR
33 4 72 15 31 50
About EDAP TMS S.A. American Depositary Shares

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms